gw-3965 and Diabetic-Nephropathies

gw-3965 has been researched along with Diabetic-Nephropathies* in 2 studies

Other Studies

2 other study(ies) available for gw-3965 and Diabetic-Nephropathies

ArticleYear
Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2.
    The American journal of pathology, 2013, Volume: 183, Issue:3

    Type 2 diabetes mellitus is characterized by dyslipidemia with elevated free fatty acids (FFAs). Loss of podocytes is a hallmark of diabetic nephropathy, and podocytes are highly susceptible to saturated FFAs but not to protective, monounsaturated FFAs. We report that patients with diabetic nephropathy develop alterations in glomerular gene expression of enzymes involved in fatty acid metabolism, including induction of stearoyl-CoA desaturase (SCD)-1, which converts saturated to monounsaturated FFAs. By IHC of human renal biopsy specimens, glomerular SCD-1 induction was observed in podocytes of patients with diabetic nephropathy. Functionally, the liver X receptor agonists TO901317 and GW3965, two known inducers of SCD, increased Scd-1 and Scd-2 expression in cultured podocytes and reduced palmitic acid-induced cell death. Similarly, overexpression of Scd-1 attenuated palmitic acid-induced cell death. The protective effect of TO901317 was associated with a reduction of endoplasmic reticulum stress. It was lost after gene silencing of Scd-1/-2, thereby confirming that the protective effect of TO901317 is mediated by Scd-1/-2. TO901317 also shifted palmitic acid-derived FFAs into biologically inactive triglycerides. In summary, SCD-1 up-regulation in diabetic nephropathy may be part of a protective mechanism against saturated FFA-derived toxic metabolites that drive endoplasmic reticulum stress and podocyte death.

    Topics: Benzoates; Benzylamines; Carnitine O-Palmitoyltransferase; Cell Death; Cells, Cultured; Diabetic Nephropathies; Fatty Acids, Monounsaturated; Gene Expression Regulation; Gene Knockdown Techniques; Gene Silencing; Humans; Hydrocarbons, Fluorinated; Kidney Glomerulus; Models, Biological; Oxidation-Reduction; Palmitic Acid; Podocytes; Protective Agents; Stearoyl-CoA Desaturase; Sulfonamides; Triglycerides

2013
Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors.
    The American journal of pathology, 2013, Volume: 182, Issue:3

    Dyslipidemia is a frequent component of the metabolic disorder of diabetic patients contributing to organ damage. Herein, in low-density lipoprotein receptor-deficient hyperlipidemic and streptozotozin-induced diabetic mice, hyperglycemia and hyperlipidemia acted reciprocally, accentuating renal injury and altering renal function. In hyperglycemic-hyperlipidemic kidneys, the accumulation of Tip47-positive lipid droplets in glomeruli, tubular epithelia, and macrophages was accompanied by the concomitant presence of the oxidative stress markers xanthine oxidoreductase and nitrotyrosine, findings that could also be evidenced in renal biopsy samples of diabetic patients. As liver X receptors (LXRα,β) regulate genes linked to lipid and carbohydrate homeostasis and inhibit inflammatory gene expression in macrophages, the effects of systemic and macrophage-specific LXR activation were analyzed on renal damage in hyperlipidemic-hyperglycemic mice. LXR stimulation by GW3965 up-regulated genes involved in cholesterol efflux and down-regulated proinflammatory/profibrotic cytokines, inhibiting the pathomorphology of diabetic nephropathy, renal lipid accumulation, and improving renal function. Xanthine oxidoreductase and nitrotyrosine levels were reduced. In macrophages, GW3965 or LXRα overexpression significantly suppressed glycated or acetylated low-density lipoprotein-induced cytokines and reactive oxygen species. Specifically, in mice, transgenic expression of LXRα in macrophages significantly ameliorated hyperlipidemic-hyperglycemic nephropathy. The results demonstrate the presence of lipid droplet-induced oxidative mechanisms and the pathophysiologic role of macrophages in diabetic kidneys and indicate the potent regulatory role of LXRs in preventing renal damage in diabetes.

    Topics: Animals; Benzoates; Benzylamines; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelial Cells; Fibrosis; Humans; Hyperglycemia; Hyperlipidemias; Inflammation; Kidney; Kidney Function Tests; Lipid Metabolism; Liver X Receptors; Macrophages; Mesangial Cells; Mice; Mice, Inbred C57BL; Orphan Nuclear Receptors; Oxidative Stress; Podocytes

2013